Chen et al. demonstrated that miR-30-5p levels were downregulated in NSCLC tissues, and that the gene and its direct target, cyclin E2 axis, may contribute to NSCLC proliferation and motility35. The gene discussed is CCNE2; the disease is non-small cell lung carcinoma.